J. Craig Venter has retired as chairman of the Synthetic Genomics board, according to a company news release.
DJO Global, which grew from a garage startup to become one of North County’s largest private employers, is laying off 187 local employees and relocating its headquarters to Texas.
MEDICINE: National Picture Expecting 4% to 5% Growth
Four major medical device companies based in San Diego recently delivered strong quarterly results, lifting their stocks and growth outlooks.
Ferhat Ay with the La Jolla Institute for Allergy and Immunology was awarded a $2.24 million grant to for research into genetic variation and disease risk.
Rady Children’s Hospital-San Diego recently held a grand opening for a medical plaza in southwest Riverside County, with the dual goal of consolidating outpatient operations and reaching more patients.
PHARMA: Versatile Co. Takes On Cancers, Infectious Diseases
Inovio Pharmaceuticals Inc. has about 300 employees, tenfold that of 2009. Most of the scaling up occurred in the last few years to support a growing pipeline of therapies targeting cancers and infectious diseases.
In quarter two earnings, Illumina continued a streak of stomping analyst expectations.
MEDICINE: Bringing Services to the Consumer Is Trend in Health Care
Forget far-off appointments and long drives to the doctor’s office.
Competing congressional priorities are clouding the path forward for an effort to kill a 2.3 percent excise tax on medical device makers, San Diego’s NuVasive and ResMed among them.
Neurocrine’s Ingrezza — the first treatment for the nervous system disorder tardive dyskinesia — continues to rake in revenue.
San Diego-based ResMed listed fourth quarter revenue as $623.6 million, a 12 percent year-over-year increase.
San Diego-based Dexcom’s stock hit $118.57 a share the morning of Aug. 2, up sharply from closing Aug. 1 at $95.44.
Special Report: Fastest-Growing Private Companies
Kevin Lustig calls Scientist.com an overnight success story a dozen years in the making.
San Diego medical device company NuVasive reported $281.6 million in second quarter earnings, an 8.5 percent year-over-year jump.
San Diego-based Omniome, maker of a DNA sequencing platform, today announced a $60 million series B round.
BIOTECH: Sleep Apnea Venture to Be 50/50 Partnership
One has the data. The other has the analytics.
Illumina in the second quarter reported revenue of $830 million, a 25 percent year-over-year increase.
Sublimity Therapeutics, an Irish pharmaceutical in the realm of gastrointestinal and immunological diseases, has set up a Solana Beach office with six employees.
PHARMA: A $230M Funding Round, Strong Leaders Are Big Pluses
By going big, Gossamer Bio looks to break the mold.
GENOMICS: Exec Says Co. Has Cash, Runway to Next Phase
New leadership at Human Longevity is seeking to emerge from a tumultuous period of executive exodus and workforce reduction through a bid to bring its genomics-based testing center to a wider market.
Molecular diagnostic company Mesa Biotech recently notched a $20 million series B round.
Health care: Diverse Mix of Cos. Driving Patient Access to Their Records
In a maturing digital health space with an urgent need to collect disparate data, think of Seqster as something of a data locker: Patients can find health records from past caregivers, genomics reports and data from wearables like Fitbit.
The House voted July 24 to repeal a 2.3 percent excise tax on medical device makers, welcome news to San Diego’s consortium of medical device companies, including NuVasive and ResMed.
Nabriva Therapeutics has acquired San Diego-based Zavante Therapeutics, known for an antibiotic to fight infections picked up in hospitals.
One Medical, an independently held primary care practice, will open three new offices in San Diego in early 2019.
Human Longevity, or HLI, has accused the former CEO and noted geneticist, J. Craig Venter, of stealing trade secrets.
Medical device company Ra Medical recently filed paperwork for an initial public offering worth up to $86.25 million.
Scripps Health in the coming months will have a dozen new walk-in clinics – offering services like flu care, vaccinations, point-of-care testing and exams.
DEVICES: Scandal Brings Welcome Scrutiny to Sector
Genalyte can run tests on drops of blood, often delivering results in only 15 minutes. The goal? Disrupt lab testing. This may sound familiar — and not in a good way.
On average, stocks of public life sciences companies in San Diego gained 12 percent during the second quarter, lifted in large part by a diabetes pump maker.
FINANCE: Ansun Led the Way With $85M Series A
Investment in San Diego-based life sciences companies hit a record high $427.5 million in the second quarter of 2018, according to a July CBRE Group Inc. report.
Sara M. Bonstein has been named the new chief operating officer and chief financial officer of San Diego-based OncoSec Medical.
Irras Ab, which is legally headquartered in Stockholm but with the bulk of operations in La Jolla, won U.S. Food and Drug Administration approval for its flagship device that reduces the chances of infection while helping doctors lessen pressure at the site of trauma.
David Karow was recently named CEO of Human Longevity, which comes after Craig Venter announced his retirement from the role on May 24.
BANKING: Finance Solutions Offered for Current Cash Business
Armored vehicles. Vaults. Talk of cryptocurrency. These are realities for San Diego marijuana businesses like Outco that are unable to obtain bank accounts.
Life sciences veteran Kieran Gallahue was named to Arena Pharmaceuticals’ board of directors.
San Diego-based Synteract has acquired Cu-Tech, and has established a center for dermatology development, with the aim of being a big player in dermatology clinical trials.
San Diego-based ResMed and Verily, a subsidiary of Google parent company Alphabet, have formed a new venture to develop software for identifying, diagnosing and treating sleep apnea and other breathing disorders.
San Diego-based Crinetics Pharmaceuticals laid out terms for a planned initial public offering in paperwork filed July 9.
WORKFORCE: Sector Stresses Opportunities to Job Candidates, Students
It’s an employment intersection that’s only growing more pronounced.
San Diego staffing company AMN Healthcare has brought Mark Hagan on board as chief information officer.
San Diego-based Beacon Discovery has added square footage and employees following partnership deals.
San Diego’s SGI-DNA, a spinout of Synthetic Genomics, has named life sciences veteran Todd Nelson as CEO.
PHARMA: Heron’s Anesthetic Aims to Reduce Opioid Use
Heron Therapeutics is now turning its attention toward commercialization of its postoperative anesthetic, riding a regulatory environment that appears to be itching for opioid alternatives.
San Diego-based Adamis Pharmaceuticals, which makes an allergy syringe, has signed over commercial rights to a division of Novartis.
DEVICES: Multipronged Plan Improves Earnings Trajectory
DJO Global CEO Brady Shirley likened the company’s business transformation plan to a knee surgery: short-term pain for long-term gain.
Mergers: Pharma Must Consider Many Factors in Buy
Earlier this month, an executive from New Jersey-based Celgene blamed Receptos, a San Diego firm that it bought, for a major regulatory setback.
San Diego-based Gossamer Bio entered into an agreement to develop and commercialize compounds from Cincinnati’s Aerpio Pharmaceuticals, in a deal worth as much as $420 million.
An associate professor with Salk Institute was named one of three winners of the Blavatnik National Awards for Young Scientists, which comes with $250,000 for her pioneering bacteria research.